Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
American Eye Institute
mi
from
New Albany, IN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
American Eye Institute
mi
from
New Albany, IN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Medical Associates Clinic, P.C.
mi
from
Dubuque, IA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Medical Associates Clinic, P.C.
mi
from
Dubuque, IA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Wolfe Eye Clinic
mi
from
West Des Moines, IA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Sabates Eye Centers Research Division
mi
from
Leawood, KA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Sabates Eye Centers Research Division
mi
from
Leawood, KA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retina and Vitreous Associates of Kentucky
mi
from
Lexington, KY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retina and Vitreous Associates of Kentucky
mi
from
Lexington, KY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Paducah Retinal Center
mi
from
Paducah, KY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Paducah Retinal Center
mi
from
Paducah, KY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Elman Retina Group, PA
mi
from
Baltimore, MD
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Elman Retina Group, PA
mi
from
Baltimore, MD
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Wilmer Eye Institute at Johns Hopkins
mi
from
Baltimore, MD
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Wilmer Eye Institute at Johns Hopkins
mi
from
Baltimore, MD
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retina Consultants of Delmarva, P.A.
mi
from
Salisbury, MD
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retina Consultants of Delmarva, P.A.
mi
from
Salisbury, MD
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Joslin Diabetes Center
mi
from
Boston, MA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Joslin Diabetes Center
mi
from
Boston, MA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
mi
from
Detroit, MI
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
mi
from
Detroit, MI
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Vitreo-Retinal Associates
mi
from
Grand Rapids, MI
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
The Retina Center
mi
from
Minneapolis, MN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
The Retina Center
mi
from
Minneapolis, MN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Barnes Retina Institute
mi
from
St. Louis, MO
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Barnes Retina Institute
mi
from
St. Louis, MO
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Delaware Valley Retina Associates
mi
from
Lawrence Twp, NJ
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Delaware Valley Retina Associates
mi
from
Lawrence Twp, NJ
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
The New York Eye and Ear Infirmary/Faculty Eye Practice
mi
from
New York, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
The New York Eye and Ear Infirmary/Faculty Eye Practice
mi
from
New York, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Mount Sinai School of Medicine, Dept. of Ophthalmology
mi
from
New York, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Mount Sinai School of Medicine, Dept. of Ophthalmology
mi
from
New York, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retina Consultants of Western New York
mi
from
Orchard Park, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retina Consultants of Western New York
mi
from
Orchard Park, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Eye Care for the Adirondacks
mi
from
Plattsburgh, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Eye Care for the Adirondacks
mi
from
Plattsburgh, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retina-Vitreous Surgeons of Central New York, PC
mi
from
Syracuse, NY
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
University of North Carolina, Dept of Ophthalmology
mi
from
Chapel Hill, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
University of North Carolina, Dept of Ophthalmology
mi
from
Chapel Hill, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Charlotte Eye Ear Nose and Throat Assoc, PA
mi
from
Charlotte, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Piedmont Retina Specialists, PA
mi
from
Greensboro, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Piedmont Retina Specialists, PA
mi
from
Greensboro, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Mid-America Retina Consultants, P.A.
mi
from
Kansas City, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Mid-America Retina Consultants, P.A.
mi
from
Kansas City, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Wake Forest University Eye Center
mi
from
Winston Salem, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Wake Forest University Eye Center
mi
from
Winston Salem, NC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retina Associates of Cleveland, Inc.
mi
from
Beachwood, OH
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retina Associates of Cleveland, Inc.
mi
from
Beachwood, OH
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Case Western Reserve Univ
mi
from
Cleveland, OH
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Case Western Reserve Univ
mi
from
Cleveland, OH
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
OSU Eye Physicians and Surgeons, LLC.
mi
from
Columbus, OH
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
OSU Eye Physicians and Surgeons, LLC.
mi
from
Columbus, OH
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retina Northwest, PC
mi
from
Portland, OR
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retina Northwest, PC
mi
from
Portland, OR
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Family Eye Group
mi
from
Lancaster, PA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Family Eye Group
mi
from
Lancaster, PA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
University of Pennsylvania Scheie Eye Institute
mi
from
Philadelphia, PA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
University of Pennsylvania Scheie Eye Institute
mi
from
Philadelphia, PA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Carolina Retina Center
mi
from
Columbia, SC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Carolina Retina Center
mi
from
Columbia, SC
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Southeastern Retina Associates, PC
mi
from
Kingsport, TN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Southeastern Retina Associates, PC
mi
from
Kingsport, TN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Southeastern Retina Associates, P.C.
mi
from
Knoxville, TN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Southeastern Retina Associates, P.C.
mi
from
Knoxville, TN
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
West Texas Retina Consultants P.A.
mi
from
Abilene, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
West Texas Retina Consultants P.A.
mi
from
Abilene, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retina Research Center
mi
from
Austin, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retina Research Center
mi
from
Austin, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retina and Vitreous of Texas
mi
from
Houston, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retina and Vitreous of Texas
mi
from
Houston, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Baylor Eye Physicians and Surgeons
mi
from
Houston, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Baylor Eye Physicians and Surgeons
mi
from
Houston, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Texas Retina Associates
mi
from
Dallas, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Texas Retina Associates
mi
from
Dallas, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Valley Retina Institute
mi
from
Harlingen, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Valley Retina Institute
mi
from
Harlingen, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Retinal Consultants of San Antonio
mi
from
San Antonio, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Medical Center Ophthalmology Associates
mi
from
San Antonio, TX
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Virginia Retina Center
mi
from
Leesburg, VA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Virginia Retina Center
mi
from
Leesburg, VA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
University of Washington Medical Center
mi
from
Seattle, WA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
University of Washington Medical Center
mi
from
Seattle, WA
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Medical College of Wiconsin
mi
from
Milwaukee, WI
Intravitreal Ranibizumab for VH Due to PDR (N)
An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Status: Archived
Updated: 1/1/1970
Medical College of Wiconsin
mi
from
Milwaukee, WI
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)
Status: Archived
Covance Clinical Research Unit, Inc.
mi
from
Daytona Beach, FL
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)
Status: Archived
Updated: 1/1/1970
Covance Clinical Research Unit, Inc.
mi
from
Daytona Beach, FL
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)
Status: Archived
Covance Clinical Research Unit, Inc.
mi
from
Honolulu, HI
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)
Status: Archived
Updated: 1/1/1970
Covance Clinical Research Unit, Inc.
mi
from
Honolulu, HI
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)
Status: Archived
Covance Clinical Research Unit
mi
from
Austin, TX
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)
Status: Archived
Updated: 1/1/1970
Covance Clinical Research Unit
mi
from
Austin, TX
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)
Status: Archived
Covance Clinical Research Unit, Inc.
mi
from
Dallas, TX
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Multicenter, Randomized, Double-Masked, Placebo-Controlled, Dose Escalation, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACU-4429 in Subjects With Dry Age-Related Macular Degeneration (Geographic Atrophy)
Status: Archived
Updated: 1/1/1970
Covance Clinical Research Unit, Inc.
mi
from
Dallas, TX